Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial

Mukherjee, S, Hurt, C, Radhakrishna, G et al. (17 more authors) (2021) Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial. European Journal of Cancer, 153. pp. 153-161. ISSN 0959-8049

Abstract

Metadata

Authors/Creators:
  • Mukherjee, S
  • Hurt, C
  • Radhakrishna, G
  • Gwynne, S
  • Bateman, A
  • Gollins, S
  • Hawkins, MA
  • Canham, J
  • Grabsch, H ORCID logo https://orcid.org/0000-0001-9520-6228
  • Falk, S
  • Sharma, RA
  • Ray, R
  • Roy, R
  • Cox, C
  • Maynard, N
  • Nixon, L
  • Sebag-Montefiore, DJ
  • Maughan, T
  • Griffiths, GO
  • Crosby, TDL
Copyright, Publisher and Additional Information: © 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Randomised controlled trial; Neoadjuvant chemoradiotherapy; Surgery; Survival; Oesophageal cancer
Dates:
  • Published: 1 August 2021
  • Accepted: 20 May 2021
  • Published (online): 19 June 2021
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 21 Jul 2021 14:33
Last Modified: 21 Jul 2021 14:48
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ejca.2021.05.020

Share / Export

Statistics